insights_auto
Why is CRSP up 3.86%?
Dive Deeperchevron_right
CRSP:NASDAQ
Crispr Therapeutics AG
$56.18
arrow_upward
+3.86%(+2.09) 1D
Sep 29, 2:37:41 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CRSP...
Open
$54.08
High
$56.43
Low
$54.00
Mkt. cap
5.43B
Avg. vol.
1.68M
Volume
942.51K
52-wk high
$78.48
52-wk low
$44.12
EPS
-$4.76
Beta
1.47
Shares outstanding
96.69M
No. of employees
393
Open
$54.08
High
$56.43
Low
$54.00
Mkt. cap
5.43B
Avg. vol.
1.68M
Volume
942.51K
52-wk high
$78.48
52-wk low
$44.12
EPS
-$4.76
Beta
1.47
Shares outstanding
96.69M
No. of employees
393
News stories
From web sources and news partners
Simply Wall Street
·
5 hours ago
CRISPR Therapeutics (CRSP) Could Be 38% Undervalued As CASGEVY Expansion Draws Focus
Zacks
·
5 hours ago
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
The Motley Fool
·
8 hours ago
CRISPR Therapeutics Has 2 Key Catalysts Coming by the End of 2026. Is the Market Underestimating Them?
Investing.com
·
1 day ago
CRISPR Therapeutics stock price target reaffirmed at $80 by Citizens
Profile
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts, won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
About Crispr Therapeutics AG
CEOSamarth Kulkarni
Employees393
Founded2013
HeadquartersZug, Zug, Switzerland
SectorBiotechnology
Websitecrisprtx.com